Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Hartley

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Journal of Neurosurgery|June 1, 1986
Reduced platelet function in subarachnoid hemorrhageS A Tsementzis, J S Gill, E R Hitchcock, et al.
British Journal of Cancer|January 1, 1997
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9S M Bailey, M D Wyatt, F Friedlos, et al.
Experimental Physiology|May 5, 2004
Volume regulation is defective in renal proximal tubule cells isolated from KCNE1 knockout miceI D Millar, J A Hartley, C Haigh, et al.
Cancer Research|March 15, 1990
Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNAK Wassermann, L A Zwelling, J W Lown, et al.
Biochemistry|March 4, 1997
Inhibition of bacteriophage T7 RNA polymerase in vitro transcription by DNA-binding pyrrolo[2,1-c][1,4]benzodiazepinesM S Puvvada, S A Forrow, J A Hartley, et al.
Journal of Medicinal Chemistry|April 28, 1995
Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomideA S Clark, B Deans, M F Stevens, et al.
Anti-Cancer Drug Design|May 17, 2001
The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl estersA M Di Francesco, R H Hargreaves, T W Wallace, et al.
Cancer Research|August 1, 1992
Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugateJ L Holley, A Mather, R T Wheelhouse, et al.
British Journal of Cancer|June 13, 2001
Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical materialS D Webley, R J Francis, R B Pedley, et al.
Biochemical Pharmacology|May 30, 2008
Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapyP H Clingen, J Y-H Wu, J Miller, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Journal of Neurosurgery|June 1, 1986
Reduced platelet function in subarachnoid hemorrhageS A Tsementzis, J S Gill, E R Hitchcock, et al.
British Journal of Cancer|January 1, 1997
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9S M Bailey, M D Wyatt, F Friedlos, et al.
Experimental Physiology|May 5, 2004
Volume regulation is defective in renal proximal tubule cells isolated from KCNE1 knockout miceI D Millar, J A Hartley, C Haigh, et al.
Cancer Research|March 15, 1990
Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNAK Wassermann, L A Zwelling, J W Lown, et al.
Biochemistry|March 4, 1997
Inhibition of bacteriophage T7 RNA polymerase in vitro transcription by DNA-binding pyrrolo[2,1-c][1,4]benzodiazepinesM S Puvvada, S A Forrow, J A Hartley, et al.
Journal of Medicinal Chemistry|April 28, 1995
Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomideA S Clark, B Deans, M F Stevens, et al.
Anti-Cancer Drug Design|May 17, 2001
The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl estersA M Di Francesco, R H Hargreaves, T W Wallace, et al.
Cancer Research|August 1, 1992
Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugateJ L Holley, A Mather, R T Wheelhouse, et al.
British Journal of Cancer|June 13, 2001
Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical materialS D Webley, R J Francis, R B Pedley, et al.
Biochemical Pharmacology|May 30, 2008
Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapyP H Clingen, J Y-H Wu, J Miller, et al.
Pageof 12